Order Article Reprints

Moral-Sanz J, Fernandez-Rojo MA, Potriquet J, Mukhopadhyay P, Brust A, Wilhelm P, Smallwood TB, Clark RJ, Fry BG, Alewood PF, et al. ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations. Toxins. 2021; 13(2):146. https://doi.org/10.3390/toxins13020146

Moral-Sanz, Javier, Manuel A. Fernandez-Rojo, Jeremy Potriquet, Pamela Mukhopadhyay, Andreas Brust, Patrick Wilhelm, Taylor B. Smallwood, Richard J. Clark, Bryan G. Fry, Paul F. Alewood, and et al. 2021. "ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations" Toxins 13, no. 2: 146. https://doi.org/10.3390/toxins13020146

Moral-Sanz, J., Fernandez-Rojo, M. A., Potriquet, J., Mukhopadhyay, P., Brust, A., Wilhelm, P., Smallwood, T. B., Clark, R. J., Fry, B. G., Alewood, P. F., Waddell, N., Miles, J. J., Mulvenna, J. P., & Ikonomopoulou, M. P. (2021). ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations. Toxins, 13(2), 146. https://doi.org/10.3390/toxins13020146